A new methodological approach, developed by researchers from SciLifeLab, could help improve breast cancer diagnostics and provide insight in the hunt for new therapeutic targets. The study was published in EBioMedicine.
Today, breast cancer analysis relies on homogenized tissue samples, something that does not provide accurate information about signaling mechanisms or cellular interactions due to the complex heterogeneity of tumors.
In a recent study, led by Mats Nilsson (SciLifeLab/Stockholm University), researchers mapped ninety-one genes, including prognostic and predictive marker profiles, in different types of breast cancer tissue using a new analytical approach involving in situ sequencing (ISS).
The new approach makes it possible to create more accurate gene expression profiles that could be assembled into a molecular-morphological map, called OncoMap, for each of the different tumor tissues.
The OncoMaps give insight into tumor progression and can help refine tumor diagnosis as well as identifying new therapeutic targets.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.